Damage to cellular DNA can result in the loss of genetic information, in cellcycle arrest or even in cell death. So DNA is constantly surveyed for the presence of lesions and appropriate responses are mounted: failure can lead to genomic instability, mutations and ultimately cancer. In the last few years, rapid progress has been made in understanding many aspects of DNA repair. For example, it has been found that tumours from patients with a hereditary form of colon cancer are defective in the repair of base mismatches in DNA. In addition, the genes involved in a number of chromosome-instability syndromes have been cloned. This primer will look at the repair of eukaryotic DNA by excision and what the recent findings tell us about DNA damage and repair in relation to disease.
What causes DNA damage?
DNA damaging agents can be divided into two main types, endogenous and exogenous, each of which can either lead to cell death or introduce mutations that will affect later generations. Water, oxygen and errors in base-pairing introduced during replication are the major endogenous sources of damage. Thus, hydrolysis is responsible for the deamination of DNA bases (for example of cytosine to uracil), and spontaneous hydrolysis of the glycosyl bond between purines and deoxyribose sugars is thought to remove the base from around 5000 sites in DNA each day in human cells. Active oxygen species, such as hydroxyl and superoxide radicals, arise during normal aerobic metabolism; guanine and thymine are their most significant targets in DNA. DNA is also subject to non-enzymatic methylation by endogenous chemicals, producing several adducts, including O 6 -methylguanine and 3-methyladenine.
Exogenous DNA-damaging agents include ultraviolet (UV) light and ionizing irradiation. Dipyrimidine photoproducts, formed from two adjacent pyrimidine residues, are the major lesions produced by UV irradiation, but UV can also damage individual bases. In contrast, ionizing radiation (such as ␥ rays and X rays) can produce potentially lethal doubleand single-strand breaks in DNA (the repair of which will not be considered further here); ionizing radiation can also lead to the production of active oxygen species.
Responses to DNA damage
Many types of DNA damage provoke stabilization of the p53 tumour suppressor protein; this stabilization has been linked to 'checkpoint' arrest of the cell cycle at the G1-S and G2-M phases, before DNA replication and mitosis, respectively; arrest is thought to allow time for cells to effect DNA repair.
The three main mechanisms by which DNA damage is repaireddirect reversal, recombination and excision -are best understood in the bacterium Escherichia coli but are generally conserved (although often more complex) in eukaryotes. The first two of these mechanisms are relatively rare. Direct reversal of damage occurs, for example, in the removal of the methyl group from the 6 position of guanine by the O 6 -methylguanine DNA methyltransferase. The effects of damage can sometimes be circumvented by tolerating the presence of a lesion in the genome; frequently this tolerance is mediated by recombination before replication. The predominant form of repair is by excision.
Excision repair
Repair by excision can be divided into three types: repair involving base excision, repair involving nucleotide excision, and DNA-mismatch repair.
The same essential principles apply to all three: the damaged region is recognized, it is removed, and a DNA polymerase and ligase replace the lost information and restore the DNA to its original state. However, the three pathways operate in different ways and on distinct types and sizes of lesion, with little or no overlap between the enzymes involved.
Base excision-repair
Base excision-repair is essential in repairing endogenous DNA damage; generally, it removes relatively small lesions that do not substantially distort the DNA helix. Base excision-repair is usually initiated by DNA glycosylases. Recent structural studies have shown that the uracil-DNA glycosylase enzyme, for example, flips its target uracil out of the DNA into the enzyme's active site, whilst minimizing distortion of the DNA double helix. The ensuing reaction leads to the formation of a single-nucleotide gap which is filled by repair-linked DNA replication.
The complete pathway of repair of uracil-containing DNA has been fully reconstituted using purified E. coli proteins; base excision-repair in mammalian cells is very similar but less well characterized (Fig. 1) . The enzymes act sequentially and, in some cases, base removal seems to be the rate-limiting step. Some DNA glycosylases are highly specific whereas others have rather broad substrate specificity. Notably, the specificities of the enzymes involved in the early stages of base excision-repair frequently overlap, providing back-up for each other.
In general, DNA glycosylases recognize and remove damaged DNA bases. In mammalian cells, however, a particular DNA glycosylase removes thymine from G · T mispairs formed when 5-methylcytosine is deaminated. Unlike uracil-DNA glycosylase, which acts rapidly, this activity is sluggish, perhaps accounting for the high proportion of GC to AT mutations at CpG sites in human tumours. The study of mammalian base excision-repair lags behind studies of the other excision-repair pathways because no naturally occurring mutants have been found -perhaps as a result of the back-up provided by overlapping enzyme specificities. Mouse genes are now being targeted and 'knockouts' generated, which should redress the balance.
Nucleotide excision-repair
Nucleotide excision-repair acts on bulky, helix-distorting lesions, such as the dipyrimidine photoproducts generated by UV light. The lesion is recognized, incisions are made some distance away along the DNA strand and a stretch of around 30 nucleotides is excised. In contrast to the proteins involved in base excision-repair, nucleotide excision-repair factors are present in a multiprotein complex and act in a highly concerted manner, protecting the large DNA gap from digestion by non-specific nucleases. The entire process requires 25-30 gene products.
Many of the proteins involved have recently been identified. Several are encoded by the genes responsible for the different complementation groups of the related human diseases xeroderma pigmentosum (XP) and Cockayne's syndrome (CS). People with XP are hypersensitive to sunlight, are predisposed to skin cancers and may also have severe neurological abnormalities. The symptoms of people with CS include severe growth retardation, sensitivity to sunlight, and an average life-span of only 12 years; CS patients are not unusually prone to cancer, however.
Several additional gene products involved in nucleotide excisionrepair, known as ERCC proteins, have been isolated as a result of their ability to complement UV-sensitive rodent cells. The nucleotide excision-repair pathway (Fig. 2a) has recently been reconstituted in vitro using highly purified proteins. One significant recent finding is that some proteins involved in nucleotide excision-repair also function in basal transcription. For example, the products of the XPB and XPD genes are components of the transcription factor TFIIH, part of the RNA polymerase II transcription-initiation complex.
It has been known for some time that mammalian cells assign nucleotide excision-repair activity to areas where it is most needed, removing some types of damage more rapidly from transcribed than non-transcribed DNA. In addition, the DNA strand used as the template for transcription is repaired preferentially. Such transcriptioncoupled repair also occurs in E. coli, where RNA polymerase stalled at a lesion is released from DNA by the Mfd (for 'mutation frequency decline') helicase, which then recruits an E. coli damage-recognition protein to the site. Patients with CS have a defect in transcription-coupled repair, and the product of the CSB gene seems to act in the same way as Mfd.
DNA-mismatch repair
The normal role of DNA-mismatch repair is to reverse errors that result from misincorporation by DNA polymerases and are missed by the polymerases' proofreading function. Mismatch repair also operates during recombination and removes inappropriate bases from 'resting' DNA. The two types of error introduced by DNA polymerases during replication are single-base mismatches and unpaired bases resulting from transient misalignment of template and daughter DNA; the formation of these looped-out bases is thought to be enhanced in simple repetitive (microsatellite) genomic sequences. In E. coli, the MutS protein recognizes both single-base mismatches and loops up to four bases in size. MutL interacts with MutS to activate a sequence-specific endonuclease that cleaves the newly replicated strand some distance away from the mismatch. A helicase aids entry of exonucleases, which degrade DNA in either a 3′ to 5′ or 5′ to 3′ direction from the incision, up to and past the site of the mispair. The gap, which can be thousands of nucleotides long, is filled in by repairreplication. The process is similar in eukaryotes (see Fig. 2b and below).
DNA repair and cancer
Recently, a direct involvement of DNA mismatch repair in cancer has been uncovered. Individuals suffering from hereditary nonpolyposis colon cancer (HNPCC) are predisposed to colon, endometrial and ovarian tumours. During the course of mapping a susceptibility gene, it was found that DNA from 498 Current Biology 1996, Vol 6 No 5
Figure 1
The main pathway of base excision-repair. A DNA glycosylase removes the aberrant base (in this case, uracil). An endonuclease then cleaves DNA 5′ to the abasic site. The resulting 5′ deoxyribose moiety is removed by a deoxyribose phosphodiesterase, and repair synthesis fills the single-base gap (DNA polymerase ␤ can fulfil both functions in mammals). The free ends are then ligated.
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T A 3' P P P P P P 5' Phosphodiesterase 5' P P P P P 3' OH DNA polymerase DNA ligase the patients' tumours exhibited an instability in microsatellite repeat sequences found throughout the genome. This similarity between mismatch repair-defective E. coli or yeast and HNPCC tumours suggested that these patients might be defective in mismatch correction. A human homologue of the yeast and E. coli mutS genes, hMSH2, was mapped to the HNPCC susceptibility region on chromosome 2, and mutations in hMSH2 were found to segregate with the disease in several HNPCC families. A second HNPCC gene, the mutL homologue hMLH1, was mapped to chromosome 3. Between them, these two genes account for around 90 % of HNPCC cases; the remainder are probably due to mutations in one of two other mutL homologues, hPMS1 and hPMS2. Mutations in hMSH2 and hMLH1 are also found in some of the sporadic colon tumours that exhibit microsatellite instability. In addition to the HNPCC genes, at least two other mismatch repair proteins have been identified by biochemical criteria. GTBP (hMSH6) and hMSH3 (DUG1/hMRP-1) are also mutS homologues. The products of both probably form heterodimers with the hMSH2 protein to participate in mismatch recognition. Mice lacking MSH2 are viable but prone to cancer and their cells are resistant to the cytotoxic effects of chemicals that produce O 6 -methylguanine; this result is consistent with the isolation of cell lines resistant to methylating agents that proved to be defective in mismatch correction. Male mice lacking the PMS2 gene are sterile and have a defect in meiosis, confirming the role of this mismatch repair protein in recombination. Interestingly, recent studies suggest that some mismatch repair proteins are also involved in transcriptioncoupled nucleotide excision-repair.
Chromosome-instability syndromes
As well as HNPCC and XP, Bloom's syndrome (BS) and ataxiatelangiectasia (AT) are genetic disorders characterized by chromosome instability and cancer predisposition. Cells from patients with AT are extremely sensitive to ionizing radiation and have abnormal radiation-induced cell-cycle checkpoint controls. It was therefore very satisfying to learn recently that the gene defective in AT patients encodes a protein homologous to phosphatidylinositol-3 kinases and other enzymes known to be involved in checkpoint controls and signal transduction pathways. BS patients have stunted growth and are sensitive to some DNA-damaging agents; unfortunately, the recent cloning of the BS gene (although an elegant technical feat), and the finding that its product has homology to a DNA helicase, does little to explain the problems of BS patients.
It is probably because DNA repair impinges on so many fundamental processes and so many diseases that its study has recently become rather fashionable. As discussed here, defects in DNA repair may lead to defects in transcription and cell-cycle control, developmental and neurological abnormalities, and to cancer.
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Figure 2
(a) Nucleotide excision-repair in mammalian cells. The initial step involves damage recognition by XPA, which is aided by replication protein A (RPA). The XPB and XPD helicases (part of the TFIIH complex) unwind the DNA to facilitate incision on either side of the lesion. The 3′ incision is catalyzed by XPG, and the 5′ incision is brought about by a complex containing XPF and ERCC1. Repair-replication is carried out by DNA polymerase ⑀ and accessory factors, and the DNA is ligated. (b) Model for the repair of single-base mispairs in human cells. The hMSH2-hMSH6 heterodimer recognizes the mispair and interacts with a heterodimer of MutL homologues. The signal directing repair to the newly replicated strand is not known for eukaryotes, but a single-strand break suffices in vitro. An ␣-type DNA polymerase performs repair replication and a DNA ligase seals the DNA backbone; hMSH2 is thought to interact with hMSH3 to repair loops. 
